Last reviewed · How we verify

Laboratorio Elea Phoenix S.A. — Portfolio Competitive Intelligence Brief

Laboratorio Elea Phoenix S.A. pipeline: 1 marketed, 0 filed, 5 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 5 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
Efavirenz, tenofovir disoproxil fumarate and emtricitabine Efavirenz, tenofovir disoproxil fumarate and emtricitabine marketed
Pembrolizumab biosimilar Pembrolizumab biosimilar phase 3 PD-1 inhibitor PD-1 Oncology
Bevacizumab (Lumiere®) Bevacizumab (Lumiere®) phase 3 Monoclonal antibody (anti-VEGF) VEGF (Vascular Endothelial Growth Factor) Oncology
Short treatment with benznidazole Short treatment with benznidazole phase 3 Nitroimidazole antiparasitic Trypanosoma cruzi DNA and proteins Infectious Disease / Parasitology
Standard treatment with benznidazole Standard treatment with benznidazole phase 3 nitroimidazole Infectious Diseases
Short regimen of benznidazole Short regimen of benznidazole phase 3 Nitroimidazole antiparasitic Trypanosoma cruzi DNA and cellular proteins Infectious Disease / Parasitology

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. ASLAN Pharmaceuticals · 1 shared drug class
  2. ATGC Co., Ltd. · 1 shared drug class
  3. Addpharma Inc. · 1 shared drug class
  4. Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class
  5. Akeso · 1 shared drug class
  6. Amgen · 1 shared drug class
  7. Asahi Kasei Pharma Corporation · 1 shared drug class
  8. 3D Medicines (Sichuan) Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Laboratorio Elea Phoenix S.A.:

Cite this brief

Drug Landscape (2026). Laboratorio Elea Phoenix S.A. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/laboratorio-elea-phoenix-s-a. Accessed 2026-05-16.

Related